Matthias Fischer, MD
- 2Articles
- 18.5KReads1
- 2010–2014Active
- 6Collaborators
- 7Citations2
About
Matthias Fischer, MD, has contributed to the field of psychopharmacology with a focus on schizophrenia and schizoaffective disorders. His publications include studies on false-positive drug screenings related to psychopharmacologic treatments, specifically involving phencyclidine and methadone during quetiapine therapy. Fischer's work, published between 2010 and 2014 in Psychiatrist.com, often involved collaboration with authors such as Andreas J. Fallgatter and Andreas Reif.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
